Department of Ophthalmology and Visual Sciences

January 21, 2016

New targets for diabetic retinopathy

Certain protein factors have been identified as attractive targets for treating diabetic retinopathy, a major cause of blindness in adults.

By VUMC News and Communications
November 12, 2015

VUMC’s Morrison named president of American Orthoptic Council

David Morrison, M.D., associate professor of Ophthalmology and Pediatrics at Vanderbilt, is the new president of the American Orthoptic Council (AOC). He will serve a two-year term.

By Jessica Pasley
June 25, 2015

Daniels receives research grant from Knights Templar Eye Foundation to study retinoblastoma treatment

Vanderbilt investigator Anthony Daniels has received a grant from the Knights Templar Eye Foundation to develop new, safe and effective treatments for retinoblastoma, the most common ocular cancer in children.

By Jessica Pasley
June 25, 2015

VEI receives grant from Research to Prevent Blindness for research and education

The Vanderbilt Eye Institute recently received a grant for $115,000 from Research to Prevent Blindness, placing the total award amount for unrestricted grants from the organization at $860,000.

By Jessica Pasley
April 23, 2015

VU mourns loss of noted ophthalmologist Elliott

A Celebration of Life service for James Howard Elliott, M.D., will be held Sunday, May 17, at noon at Benton Chapel.

By Jessica Pasley
March 23, 2015

Beware the eyes of March: Vanderbilt ophthalmologist offers tips for preventing and treating dry eyes during windy weather

By Jessica Pasley
February 12, 2015

VUMC’s Penn named president-elect of eye research society

John Penn, Ph.D., Phyllis G and William B. Snyder Endowed Professor of Ophthalmology and Visual Sciences, has been named president-elect of the International Society for Eye Research (ISER).
By Jessica Pasley
December 16, 2014

Retinal neuron survival in glaucoma

Understanding how the protein TRPV1 helps neurons survive after glaucoma-related stressors could lead to new therapeutic strategies for glaucoma and other neurodegenerative conditions.
By Leigh MacMillan
November 24, 2014

Twelve Vanderbilt faculty elected AAAS fellows

Twelve members of Vanderbilt's faculty have been elected fellows of the American Association for the Advancement of Science for their “scientifically or socially distinguished efforts to advance science or its applications.”
By Bill Snyder
October 16, 2014

Project PAVE’s impact on children’s vision easy to see

It’s been 20 years since Project PAVE, a Tennessee program providing low-vision evaluations for children, was launched.
By Jessica Pasley
October 9, 2014

Novel therapy eases stress of retinoblastoma treatment

Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.
By Jessica Pasley
October 2, 2014

Regenerative visual neuroscience effort launched

Vanderbilt University has launched a regenerative visual neuroscience initiative to develop new ways of treating — and restoring sight to — people who have been blinded by glaucoma, macular degeneration, diabetic retinopathy and eye injuries.
By Bill Snyder
September 26, 2014

Biomarker for diabetic eye disease

A person’s mitochondrial gene “signature” could predict risk for diabetic retinopathy and guide early intervention strategies.
By Leigh MacMillan
1 … 5 6 7 8 9 10